Table 1 Comparison of clinicopathological parameters of conventional UC, PUC and MPC urothelial carcinomas treated with radical cystectomy and adjuvant cisplatin based chemotherapy
Total | UC | PUC | MPC | P-Value* | |
|---|---|---|---|---|---|
Age | 0.057** | ||||
Range | 29-75 | 29-75 | 46-70 | 56-70 | |
Mean | 60.9 | 61.0 | 57.9 | 62.3 | |
Median | 61.7 | 61.9 | 59.3 | 60.8 | |
Gender | 205 | 178 | 18 | 9 | 0.116 |
Female | 45 (22%) | 43 (24%) | 2 (11%) | 0 (0%) | |
Male | 160 (78%) | 135 (76%) | 16 (89%) | 9 (100%) | |
pT | 205 | 178 | 18 | 9 | 0.168 |
pT1 | 5 (2,5%) | 5 (3%) | 0 (%) | 0 (0%) | |
pT2 | 22 (11%) | 19 (11%) | 3 (17%) | 0 (0%) | |
pT3 | 142 (69%) | 125 (70%) | 13 (72%) | 4 (45%) | |
pT4 | 36 (17.5%) | 29 (16%) | 2 (11%) | 5 (55%) | |
Grade (1973) | 205 | 178 | 18 | 9 | 0.263 |
Grade 2 | 22 (11%) | 22 (12%) | 0 (0%) | 0 (0%) | |
Grade 3 | 183 (89%) | 156 (88%) | 18 (100%) | 9 (100%) | |
Grade (2004) | |||||
Low-grade | 0% | 0% | 0% | 0% | |
High-grade | 100% | 100% | 100% | 100% | |
pN | 205 | 178 | 18 | 9 | 0.743 |
pN0 | 90 (44%) | 80 (45%) | 6 (33%) | 4 (44.4%) | |
pN1 | 45 (22%) | 40 (22.5%) | 3 (17%) | 2 (22.2%) | |
pN2 | 69 (33.5%) | 57 (32%) | 9 (50%) | 3 (33.3%) | |
pN3 | 1 (0.5%) | 1 (0.5%) | 0 (0%) | 0 (0%) | |
pM | 205 | 178 | 18 | 9 | 1.000 |
pM0 | 204 (99.5%) | 177 | 18 (100%) | 9 (100%) | |
pM1 | 1 (0.5%) | 1 | 0 (0%) | 0 (0%) | |
Chemotherapy | 205 | 178 | 18 | 9 | 0.043 |
Gc | 39 | 39 (%) | 0 (0%) | 0 (0%) | |
M-vec | 80 | 64 (%) | 11 (61%) | 5 (55%) | |
Cm | 86 | 75 (%) | 7 (39%) | 4 (45%) | |
Survival | 205 | 178 | 18 | 9 | 0.061 |
Alive | 120 | 109 | 6 (33.3%) | 5 (55%) | |
Dead | 85 | 69 | 12 (66.6%) | 4 (45%) |